Literature DB >> 3664484

Retinoic acid-induced rapid loss of nuclear cyclic AMP-dependent protein kinase in teratocarcinoma cells.

A Plet1, D Evain-Brion, P Gerbaud, W B Anderson.   

Abstract

To determine what effect retinoic acid might have in modulating cyclic AMP-mediated events at the nucleus of teratocarcinoma cells, we have investigated the effect of retinoic acid treatment of F9 and PC13 cells on cyclic AMP-dependent protein kinase activity and the amounts of the RI and RII cyclic AMP binding proteins present in the nuclear fraction. Exposure of F9 cells to retinoic acid (0.1 microM) induces differentiation to parietal endoderm, while retinoic acid treatment (3 microM) of PC13 cells induces differentiation to visceral endoderm. In both cell types retinoic acid treatment causes a rapid (within 4 h) and pronounced (by 2-fold) decrease in nuclear cyclic AMP-dependent protein kinase activity. Conversely, as measured by cyclic [8-azido-32P]AMP photoaffinity labeling a similar rapid and pronounced decrease in the RI and RII regulatory subunits is observed at the nucleus. This decrease in nuclear cyclic AMP-dependent protein kinases in at least two cell types may be an early event of retinoid action important in the initiation of differentiation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3664484

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line.

Authors:  Meng-Sen Li; Ping-Feng Li; Shi-Peng He; Guo-Guang Du; Gang Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

2.  Co-regulative effects of the cAMP/PKA and DAG/PKC signal pathways on human gastric cancer cells during differentiation induced by traditional Chinese medicines.

Authors:  S Q Gu; Y Y Liang; L R Fan; B Y Li; D S Wang
Journal:  World J Gastroenterol       Date:  1997-03-15       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.